The Impact of a Comprehensive Risk Prediction Model for Colorectal Cancer on a Population Screening Program

被引:7
作者
Saya, Sibel [1 ,2 ]
Emery, Jon D. [1 ,2 ]
Dowty, James G. [3 ]
McIntosh, Jennifer G. [1 ,2 ]
Winship, Ingrid M. [4 ,5 ]
Jenkins, Mark A. [3 ]
机构
[1] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Gen Practice, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Fac Med Dent & Hlth Sci, Ctr Canc Res, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Genom Med & Family Canc Clin, Melbourne, Vic, Australia
[5] Univ Melbourne, Fac Med Dent & Hlth Sci, Dept Med, Melbourne, Vic, Australia
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; POLYGENIC RISK; SUSCEPTIBILITY LOCI; GENERAL-PRACTICE; GENETIC RISK; BREAST; PREVENTION; GUIDELINES; WOMEN;
D O I
10.1093/jncics/pkaa062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In many countries, population colorectal cancer (CRC) screening is based on age and family history, though more precise risk prediction could better target screening. We examined the impact of a CRC risk prediction model (incorporating age, sex, lifestyle, genomic, and family history factors) to target screening under several feasible screening scenarios. Methods: We estimated the model's predicted CRC risk distribution in the Australian population. Predicted CRC risks were categorized into screening recommendations under 3 proposed scenarios to compare with current recommendations: 1) highly tailored, 2) 3 risk categories, and 3) 4 sex-specific risk categories. Under each scenario, for 35- to 74-year-olds, we calculated the number of CRC screens by immunochemical fecal occult blood testing (iFOBT) and colonoscopy and the proportion of predicted CRCs over 10 years in each screening group. Results: Currently, 1.1% of 35- to 74-yearolds are recommended screening colonoscopy and 56.2% iFOBT, and 5.7% and 83.2% of CRCs over 10 years were predicted to occur in these groups, respectively. For the scenarios, 1) colonoscopy was recommended to 8.1% and iFOBT to 37.5%, with 36.1% and 50.1% of CRCs in each group; 2) colonoscopy was recommended to 2.4% and iFOBT to 56.0%, with 13.2% and 76.9% of cancers in each group; and 3) colonoscopy was recommended to 5.0% and iFOBT to 54.2%, with 24.5% and 66.5% of cancers in each group. Conclusions: A highly tailored CRC screening scenario results in many fewer screens but more cancers in those unscreened. Category-based scenarios may provide a good balance between number of screens and cancers detected and are simpler to implement.
引用
收藏
页数:7
相关论文
共 56 条
[11]   Implications of polygenic risk for personalised colorectal cancer screening [J].
Frampton, M. J. E. ;
Law, P. ;
Litchfield, K. ;
Morris, E. J. ;
Kerr, D. ;
Turnbull, C. ;
Tomlinson, I. P. ;
Houlston, R. S. .
ANNALS OF ONCOLOGY, 2016, 27 (03) :429-434
[12]   Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors [J].
Frampton, Matthew ;
Houlston, Richard S. .
GENETICS IN MEDICINE, 2017, 19 (03) :314-321
[13]  
Gormley KM., 2017, CANC COUNCIL AUSTR C
[14]  
Hopper John L, 2011, Epidemiol Perspect Innov, V8, P2, DOI 10.1186/1742-5573-8-2
[15]   Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer [J].
Houlston, Richard S. ;
Webb, Emily ;
Broderick, Peter ;
Pittman, Alan M. ;
Di Bernardo, Maria Chiara ;
Lubbe, Steven ;
Chandler, Ian ;
Vijayakrishnan, Jayaram ;
Sullivan, Kate ;
Penegar, Steven ;
Carvajal-Carmona, Luis ;
Howarth, Kimberley ;
Jaeger, Emma ;
Spain, Sarah L. ;
Walther, Axel ;
Barclay, Ella ;
Martin, Lynn ;
Gorman, Maggie ;
Domingo, Enric ;
Teixeira, Ana S. ;
Kerr, David ;
Cazier, Jean-Baptiste ;
Niittymaki, Iina ;
Tuupanen, Sari ;
Karhu, Auli ;
Aaltonen, Lauri A. ;
Tomlinson, Ian P. M. ;
Farrington, Susan M. ;
Tenesa, Albert ;
Prendergast, James G. D. ;
Barnetson, Rebecca A. ;
Cetnarskyj, Roseanne ;
Porteous, Mary E. ;
Pharoah, Paul D. P. ;
Koessler, Thibaud ;
Hampe, Jochen ;
Buch, Stephan ;
Schafmayer, Clemens ;
Tepel, Jurgen ;
Schreiber, Stefan ;
Voelzke, Henry ;
Chang-Claude, Jenny ;
Hoffmeister, Michael ;
Brenner, Hermann ;
Zanke, Brent W. ;
Montpetit, Alexandre ;
Hudson, Thomas J. ;
Gallinger, Steven ;
Campbell, Harry ;
Dunlop, Malcolm G. .
NATURE GENETICS, 2008, 40 (12) :1426-1435
[16]   A Model to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci [J].
Hsu, Li ;
Jeon, Jihyoun ;
Brenner, Hermann ;
Gruber, Stephen B. ;
Schoen, Robert E. ;
Berndt, Sonja I. ;
Chan, Andrew T. ;
Chang-Claude, Jenny ;
Du, Mengmeng ;
Gong, Jian ;
Harrison, Tabitha A. ;
Hayes, Richard B. ;
Hoffmeister, Michael ;
Hutter, Carolyn M. ;
Lin, Yi ;
Nishihara, Reiko ;
Ogino, Shuji ;
Prentice, Ross L. ;
Schumacher, Fredrick R. ;
Seminara, Daniela ;
Slattery, Martha L. ;
Thomas, Duncan C. ;
Thornquist, Mark ;
Newcomb, Polly A. ;
Potter, John D. ;
Zheng, Yingye ;
White, Emily ;
Peters, Ulrike .
GASTROENTEROLOGY, 2015, 148 (07) :1330-+
[17]   Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history [J].
Jenkins, Mark A. ;
Win, Aung K. ;
Dowty, James G. ;
MacInnis, Robert J. ;
Makalic, Enes ;
Schmidt, Daniel F. ;
Dite, Gillian S. ;
Kapuscinski, Mirosl ;
Clendenning, Mark ;
Rosty, Christophe ;
Winship, Ingrid M. ;
Emery, Jon D. ;
Saya, Sibel ;
Macrae, Finlay A. ;
Ahnen, Dennis J. ;
Duggan, David ;
Figueiredo, Jane C. ;
Lindor, Noralane M. ;
Haile, Robert W. ;
Potter, John D. ;
Cotterchio, Michelle ;
Gallinger, Steven ;
Newcomb, Polly A. ;
Buchanan, Daniel D. ;
Casey, Graham ;
Hopper, John L. .
FAMILIAL CANCER, 2019, 18 (04) :389-397
[18]   Revised Australian national guidelines for colorectal cancer screening: family history [J].
Jenkins, Mark A. ;
Ouakrim, Driss Ait ;
Boussioutas, Alex ;
Hopper, John L. ;
Ee, Hooi C. ;
Emery, Jon D. ;
Macrae, Finlay A. ;
Chetcuti, Albert ;
Wuellner, Laura ;
St John, D. James B. .
MEDICAL JOURNAL OF AUSTRALIA, 2018, 209 (10) :455-+
[19]   Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC) [J].
Jenkins, Mark A. ;
Win, Aung Ko ;
Templeton, Allyson S. ;
Angelakos, Maggie S. ;
Buchanan, Daniel D. ;
Cotterchio, Michelle ;
Figueiredo, Jane C. ;
Thibodeau, Stephen N. ;
Baron, John A. ;
Potter, John D. ;
Hopper, John L. ;
Casey, Graham ;
Gallinger, Steven ;
Le Marchand, Loic ;
Lindor, Noralane M. ;
Newcomb, Polly A. ;
Haile, Robert W. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) :387-+
[20]   Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screening [J].
Jenkins, Mark A. ;
Makalic, Enes ;
Dowty, James G. ;
Schmidt, Daniel F. ;
Dite, Gillian S. ;
MacInnis, Robert J. ;
Ouakrim, Driss Ait ;
Clendenning, Mark ;
Flander, Louisa B. ;
Stanesby, Oliver K. ;
Hopper, John L. ;
Win, Aung K. ;
Buchanan, Daniel D. .
FUTURE ONCOLOGY, 2016, 12 (04) :503-513